U.S. Department of Health and Human Services Awards CITI and C3 AI $90 Million Agreement

Rhea-AI Summary

The U.S. Department of Health and Human Services (HHS) has awarded a $90 million, five-year Blanket Purchase Agreement (BPA) to C3 AI (NYSE: AI) and CITI through Carahsoft. This agreement, titled 'Solutioning with Holistic Analytics Restructured for the Enterprise (SHARE),' aims to expedite enterprise AI solutions across HHS agencies, including NIH, FDA, and CDC. C3 AI's platforms will support data-driven initiatives and aid public health challenges. Notably, C3 AI has contributed over $5 million in funding for COVID-19 research over the past two years.

Positive

• Awarded a $90 million, five-year BPA to accelerate AI deployment across HHS agencies.
• Increased potential for revenue from government contracts through this partnership.
• Enhanced capabilities in addressing public health challenges, specifically for future pandemics.

Negative

• None.

The joint Blanket Purchase Agreement will enable HHS to rapidly deploy and scale enterprise AI solutions across the department, including the NIH, FDA, and CDC

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- The U.S. Department of Health and Human Services (HHS) has awarded a joint $90 million, five-year agreement to CITI, the software services and product company, and C3 AI (NYSE: AI), the Enterprise AI application software company, through its partnership with Carahsoft.

The Blanket Purchase Agreement (BPA), called “Solutioning with Holistic Analytics Restructured for the Enterprise (SHARE),” will accelerate enterprise AI deployments across the entire HHS, which includes the National Institutes of Health (NIH), the Food and Drug Administration (FDA), and the Centers for Disease Control and Prevention (CDC).

Through the SHARE BPA, the HHS’s various agencies and missions can select C3 AI to support data-driven work. For example, the HHS can leverage the C3 AI Application Platform to rapidly deploy use cases and scale AI applications to solve public health challenges in the event of a future pandemic. The BPA allows HHS officials to procure CITI services, C3 AI applications, and C3 AI’s secure and powerful AI platform for data collection, analysis with machine learning, and predictive AI capabilities.

“Our public health agencies, including the FDA and CDC, are under incredible pressure to solve complex, life-threatening problems, ranging from supply chain optimization for baby formula to understanding and thwarting the next global pandemic. These problems cannot be solved without machine learning and enterprise AI capabilities,” said Thomas M. Siebel, Chairman and CEO of C3 AI. “We are proud to deliver the world’s leading AI technologies, people, and partners to HHS, and we look forward to supporting the department’s vital missions.”

“I am very pleased to partner with C3 AI and provide agile development services to HHS agencies to integrate the C3 AI platform via this new SHARE BPA,” said Sunil Kolhekar, President and CEO of CITI.

Over the past two years, C3 AI’s software has been used extensively by data and research communities to combat the COVID-19 pandemic, while CITI has been at the forefront of developing applications to process expedited payments for farmers hurt by COVID. In April 2020, C3 AI deployed the C3 AI COVID-19 Data Lake to provide the global research community access to critical data to aid mitigation efforts. C3 AI also supported COVID-19-related research through various grant and funding programs, awarding more than $5 million in funding to research teams in 2020 through the C3.ai Digital Transformation Institute and C3 AI COVID-19 Grand Challenge.

C3 AI products are provided via General Services Administration (GSA) Schedules contract with Carahsoft. The BPA No. is 75P001-22-A-00009.

For more information on C3 AI and Enterprise AI solutions, visit https://c3.ai/what-is-enterprise-ai/.

About C3.ai, Inc.

C3 AI is the Enterprise AI application software company. C3 AI delivers a family of fully integrated products including the C3 AI Application Platform, an end-to-end platform for developing, deploying, and operating enterprise AI applications and C3 AI Applications, a portfolio of industry-specific SaaS enterprise AI applications that enable the digital transformation of organizations globally.

About CITI - US

The company was founded in 1996 and is based in Falls Church, Virginia, with offices across the United States, Europe, South Asia, and Canada. CITI is a varied organization with a broad group of IT and business experts providing services to the Federal Government, State &Local and commercial. CITI is a product innovator and has built several enterprise class products in Health and Human Services market using agile and DevSecOps methodologies. CITI’s products modernize use cases for Child Subsidy, Child Welfare and Child Support, Healthcare and Identity Management. CITI holds certifications for ISO 9001:2015, ISO 20000-1:2011, ISO 27001:2013, and CMMI-DEV Maturity Level 4. CITI specializes in the innovative application of agile processes and new technologies as a Microsoft Gold Partner.

For more information on services and products offered by CITI, visit http://citi-us.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220628005470/en/

C3 AI Public Relations

Edelman

Lisa Kennedy

415-914-8336

pr@c3.ai

Investor Relations

IR@C3.ai

Source: C3.ai

FAQ

What is the significance of the $90 million agreement for C3 AI (NYSE: AI)?

The $90 million agreement allows C3 AI to provide enterprise AI solutions to HHS, potentially increasing revenue and market presence.

Which agencies will benefit from the C3 AI and HHS partnership?

The partnership will benefit the National Institutes of Health (NIH), Food and Drug Administration (FDA), and Centers for Disease Control and Prevention (CDC).

How does C3 AI plan to use the funding from the HHS agreement?

C3 AI will use the funding to deploy AI applications that support data-driven initiatives and address public health challenges.

What is the SHARE BPA mentioned in the press release?

The SHARE BPA is a Blanket Purchase Agreement that aims to accelerate the deployment of enterprise AI solutions within the HHS.